GPT and Hepatic failure: In the above phase III studies of tolcapone, elevations of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) above 3 times the upper limit of normal were seen in approximately 1–3% of patients, although no cases of hepatic failure were observed.